Literature DB >> 26095488

Fentanyl tolerance in the treatment of cancer pain: a case of successful opioid switching from fentanyl to oxycodone at a reduced equivalent dose.

Ichiro Sutou, Toshihiko Nakatani, Tatsuya Hashimoto, Yoji Saito.   

Abstract

Opioids are not generally deemed to have an analgesic ceiling effect on cancer pain. However, there have been occasional reports of tolerance to opioid development induced by multiple doses of fentanyl. The authors report a case of suspected tolerance to the analgesic effect of opioid, in which an increasing dose of fentanyl failed to relieve the patient's cancer pain symptoms, but opioid switching to oxycodone injections enabled a dose reduction to below the equivalent dose conversion ratio. The patient was a 60-year-old man diagnosed with pancreatic body carcinoma with multiple metastases. The base dose consisted of 12 mg/day of transdermal fentanyl patches (equivalent to 3.6 mg/day, 150 μg/h fentanyl injection), and rescue therapy consisted of 10 mg immediate-release oxycodone powders. Despite the total daily dose of fentanyl reaching 5.6 mg (equivalent to 560 mg oral morphine), the analgesic effect was inadequate; thus, an urgent adjustment was necessary. Due to the moderate dose of fentanyl, the switch to oxycodone injection was done incrementally at a daily dose equivalent to 25% of the fentanyl injection. The total dose of oxycodone was replaced approximately 53.5% of the dose of fentanyl prior to opioid switching.

Entities:  

Keywords:  cancer pain; fentanyl; opioid switching; oxycodone; tolerance to the analgesic effect of opioid

Mesh:

Substances:

Year:  2015        PMID: 26095488     DOI: 10.3109/15360288.2015.1035832

Source DB:  PubMed          Journal:  J Pain Palliat Care Pharmacother        ISSN: 1536-0288


  2 in total

1.  Covalently Loaded Naloxone Nanoparticles as a Long-Acting Medical Countermeasure to Opioid Poisoning.

Authors:  Andrew J Kassick; Mariah Wu; Diego Luengas; Mohammad Ebqa'ai; L P Tharika Nirmani; Nestor Tomycz; Toby L Nelson; Marco Pravetoni; Michael D Raleigh; Saadyah Averick
Journal:  ACS Pharmacol Transl Sci       Date:  2021-08-26

2.  Successful treatment of refractory cancer pain with morphine and ropivacaine: A case report.

Authors:  Hongyan Li; Liqiang Yang; Zhaoxuan Guo; Yuanzhang Tang; Nan Chen; Yinying Lu; Jiaxiang Ni
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.